{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:19:24Z","timestamp":1790965164905,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/hjh.0b013e32832e1bd9","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T07:16:26Z","timestamp":1250666186000},"page":"1863-1872","source":"Crossref","is-referenced-by-count":88,"title":["The effects of \u03c93 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial"],"prefix":"10.1097","volume":"27","author":[{"given":"Trevor A","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B","family":"Puddey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A","family":"Cowpland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J","family":"Beilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gursharan K","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210208","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-20-20210208","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-20-20210208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(00)02456-9","article-title":"Premature cardiovascular disease in chronic renal failure","volume":"356","author":"Baigent","year":"2000","journal-title":"Lancet"},{"key":"R5-20-20210208","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/archinte.166.17.1884","article-title":"Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control","volume":"166","author":"Parikh","year":"2006","journal-title":"Arch Intern Med"},{"key":"R6-20-20210208","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00004872-199208000-00002","article-title":"Hypertension in human renal disease","volume":"10","author":"Brown","year":"1992","journal-title":"J Hypertens"},{"key":"R7-20-20210208","first-page":"151","article-title":"International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines subcommittee.","volume":"17","year":"1999","journal-title":"J Hypertens"},{"key":"R8-20-20210208","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/j.ajkd.2006.08.008","article-title":"Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD","volume":"48","author":"Dogra","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R9-20-20210208","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study","volume":"58","author":"Muntner","year":"2000","journal-title":"Kidney Int"},{"key":"R10-20-20210208","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.thromres.2004.09.007","article-title":"Marine n-3 polyunsaturated fatty acids and CHD: part II. Clinical trials and recommendations","volume":"115","author":"Schmidt","year":"2005","journal-title":"Thromb Res"},{"key":"R11-20-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00041433-200102000-00003","article-title":"\u03c93 Fatty acids, blood lipids and cardiovascular risk reduction","volume":"12","author":"Mori","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"R12-20-20210208","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.ejcn.1601464","article-title":"Coenzyme Q(10) improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes","volume":"56","author":"Hodgson","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"R13-20-20210208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-001-0760-y","article-title":"Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in type II diabetes mellitus","volume":"45","author":"Watts","year":"2002","journal-title":"Diabetologia"},{"key":"R14-20-20210208","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(02)00417-3","article-title":"Combined effect of coenzyme Q(10) and fenofibrate on forearm microcirculatory function in type 2 diabetes","volume":"168","author":"Playford","year":"2003","journal-title":"Atherosclerosis"},{"key":"R16-20-20210208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.HYP.32.4.710","article-title":"Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives","volume":"32","author":"Bao","year":"1998","journal-title":"Hypertension"},{"key":"R17-20-20210208","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.HYP.34.2.253","article-title":"Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans","volume":"34","author":"Mori","year":"1999","journal-title":"Hypertension"},{"key":"R18-20-20210208","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ajcn\/76.5.1007","article-title":"Effects of purified eicosapentaenoic acid and docosahexaenoic acid on glycaemic control, blood pressure and serum lipids in treated-hypertensive type 2 diabetic patients","volume":"76","author":"Woodman","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"R19-20-20210208","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/ajcn\/71.5.1085","article-title":"Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects of on serum lipids and lipoproteins, LDL: particle size, glucose and insulin, in mildly hyperlipidaemic men","volume":"71","author":"Mori","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"R20-20-20210208","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9150(01)00770-5","article-title":"Leukocyte count and vascular function in type 2 diabetic patients with treated hypertensions","volume":"163","author":"Woodman","year":"2002","journal-title":"Atherosclerosis"},{"key":"R21-20-20210208","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11745-998-0274-y","article-title":"Analysis of ubiquinone and tocopherol levels in normal and hyperlipidemic human plasma","volume":"33","author":"Zhang","year":"1998","journal-title":"Lipids"},{"key":"R22-20-20210208","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1523-1755.2001.00785.x","article-title":"Vascular function of the peripheral circulation in patients with nephrosis","volume":"60","author":"Watts","year":"2001","journal-title":"Kid Int"},{"key":"R23-20-20210208","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/jappl.2001.91.2.929","article-title":"Improved analysis of brachial artery ultrasound using a novel edge-detection software system","volume":"91","author":"Woodman","year":"2001","journal-title":"J Appl Physiol"},{"key":"R24-20-20210208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-9150(02)00307-6","article-title":"Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrilolytic and vascular function in type 2 diabetic patients","volume":"166","author":"Woodman","year":"2003","journal-title":"Atherosclerosis"},{"key":"R25-20-20210208","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"key":"R26-20-20210208","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.CIR.102.11.1264","article-title":"Differential effects of eicosapentaenoic acid and docosahexaenoic acid on forearm vascular reactivity of the microcirculation in hyperlipidaemic, overweight men","volume":"102","author":"Mori","year":"2000","journal-title":"Circulation"},{"key":"R28-20-20210208","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"R29-20-20210208","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.158.12.1340","article-title":"Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program","volume":"158","author":"Pahor","year":"1998","journal-title":"Arch Intern Med"},{"key":"R30-20-20210208","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/ndt\/12.4.724","article-title":"Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure","volume":"12","author":"Tucker","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"R31-20-20210208","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ndt\/18.3.563","article-title":"Nondipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients","volume":"18","author":"Liu","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R32-20-20210208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0272-6386(12)80896-1","article-title":"n-3 fatty acids and renal diseases","volume":"24","author":"Decaterina","year":"1994","journal-title":"Am J Kidney Diseases"},{"key":"R33-20-20210208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semnephrol.2004.01.004","article-title":"The role of fish oil\/omega-3 fatty acids in the treatment of IgA nephropathy","volume":"24","author":"Donadio","year":"2004","journal-title":"Seminars Nephrol"},{"key":"R34-20-20210208","first-page":"77","article-title":"Dietary fats and blood pressure","author":"Mori","year":"2007"},{"key":"R35-20-20210208","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00004872-200208000-00010","article-title":"Blood pressure response to fish oil supplementation: meta-regression analysis of randomized trials","volume":"20","author":"Geleijnse","year":"2002","journal-title":"J Hypertens"},{"key":"R36-20-20210208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2004.03.024","article-title":"The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF","volume":"44","author":"Svensson","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R37-20-20210208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004872-199201000-00014","article-title":"A low sodium diet supplemented with fish oil lowers blood pressure in the elderly","volume":"10","author":"Cobiac","year":"1992","journal-title":"J Hypertens"},{"key":"R38-20-20210208","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.105.556886","article-title":"Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials","volume":"112","author":"Mozaffarian","year":"2005","journal-title":"Circulation"},{"issue":"5 Suppl","key":"R39-20-20210208","doi-asserted-by":"crossref","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"n-3 fatty acids and serum lipoproteins: human studies","volume":"65","author":"Harris","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"R40-20-20210208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/biof.5520090224","article-title":"Overview of the use of CoQ10 in cardiovascular disease","volume":"9","author":"Langsjoen","year":"1999","journal-title":"Biofactors"},{"key":"R41-20-20210208","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1592\/phco.21.9.797.34564","article-title":"Role of coenzyme Q(10) in chronic heart failure, angina, and hypertension","volume":"21","author":"Tran","year":"2001","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-200909000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:03:54Z","timestamp":1618365834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200909000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32832e1bd9","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}